What happens after fingolimod discontinuation? A multicentre real-life experience

ConclusionsThe main reason for the discontinuation of fingolimod was inefficacy. One-third of the patients had a relapse during the year after discontinuation, 15% experienced a severe reactivation, and approximately 50% of patients with available MRI scan had new/enhancing lesions. The risk factors for disease activity after discontinuation were low lymphocyte count and younger age.
Source: Journal of Neurology - Category: Neurology Source Type: research